On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Robert Pirker

ResearcherPublications, citations & collaboration network

Robert Pirker is a researcher indexed in ScholarIQ from OpenAlex & ORCID.

How many works does Robert Pirker have?

ScholarIQindexed works

Robert Pirker has 352 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Robert Pirker have?

ScholarIQcitation count

Robert Pirker has 18,039 citations in the OpenAlex counts ScholarIQ stores.

What is the h-index of Robert Pirker?

ScholarIQh-index

Robert Pirker has an h-index of 60 in OpenAlex.

What is the i10-index of Robert Pirker?

ScholarIQi10-index

Robert Pirker has an i10-index of 172 in OpenAlex.

What is the ORCID of Robert Pirker?

ScholarIQorcid

The ORCID for Robert Pirker is on the source record.

What is the OpenAlex record for Robert Pirker?

ScholarIQopenalex

The OpenAlex for Robert Pirker is on the source record.

What are the most-cited papers on Robert Pirker?

ScholarIQmost cited works
Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial
Robert Pirker, Jose R. Pereira, Aleksandra Szczęsna, Joachim von Pawel, Maciej Krzakowski, Rodryg Ramlau, Ihor Vynnychenko, Keunchil Park, Chih-Teng Yu, Valentyn Ganul, Jae-Kyung Roh, Emilio Bajetta, Kenneth J. O’Byrne, Filippo de Marinis, Wilfried Eberhardt, Thomas Goddemeier, Michael Emig, U. Gatzemeier
The Lancet. 20091,356 CitationsOPEN ACCESS
Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC
Christian Rolfo, Philip C. Mack, Giorgio V. Scagliotti, Paul Baas, Fabrice Barlési, Trever G. Bivona, Roy S. Herbst, Tony Mok, Nir Peled, Robert Pirker, Luis E. Raez, Martin Reck, Jonathan W. Riess, Lecia V. Sequist, Frances A. Shepherd, Lynette M. Sholl, Daniel Shao-Weng Tan, Heather A. Wakelee, Ignacio I. Wistuba, Murry W. Wynes, David P. Carbone, Fred R. Hirsch, David R. Gandara
Journal of Thoracic Oncology. 2018668 CitationsOPEN ACCESS
Effect of Anlotinib as a Third-Line or Further Treatment on Overall Survival of Patients With Advanced Non–Small Cell Lung Cancer
Baohui Han, Kai Li, Qiming Wang, Li Zhang, Jianhua Shi, Zhehai Wang, Ying Cheng, Jianxing He, Yuankai Shi, Yizhuo Zhao, Hao Yu, Yang Zhao, Weiqiang Chen, Yi Luo, Lin Wu, Xiuwen Wang, Robert Pirker, Kejun Nan, Faguang Jin, Jian Dong, Baolan Li, Yan Sun
JAMA Oncology. 2018627 CitationsOPEN ACCESS
Prognostic Effect of Tumor Lymphocytic Infiltration in Resectable Non–Small-Cell Lung Cancer
Élisabeth Brambilla, Gwénaël Le Teuff, Sophie Marguet, Sylvie Lantuéjoul, Ariane Dunant, Stephen L. Graziano, Robert Pirker, Jean-Yves Douillard, Thierry Le Chevalier, Martin Filipits, Rafael Rosell, Robert A. Kratzke, Helmut Popper, Jean‐Charles Soria, Frances A. Shepherd, Lesley Seymour, Ming‐Sound Tsao
Journal of Clinical Oncology. 2016363 CitationsOPEN ACCESS

Related on ScholarIQ

470M+ articles · free account